Research Alert: CFRA Keeps Strong Buy Opinion On Adss Of Astrazeneca Plc
AstraZeneca Analyst Ratings
Analysts' Top Healthcare Picks: AstraZeneca (AZN), Centessa Pharmaceuticals (CNTA)
Analysts Are Bullish on Top Healthcare Stocks: Siemens Healthineers AG (SEMHF), AstraZeneca (AZN)
AstraZeneca's Ultomiris Approval Spurs Buy Rating Amid Growth in Rare Disease Segment
Analysts Offer Insights on Healthcare Companies: Structure Therapeutics, Inc. Sponsored ADR (GPCR), AstraZeneca (AZN) and Biohaven Ltd. (BHVN)
Research Alert: CFRA Keeps Strong Buy Opinion On Adss Of Astrazeneca Plc
Fusion Pharmaceuticals: Hold Rating Affirmed Post-AstraZeneca Acquisition Announcement
Fusion Pharmaceuticals: Hold Rating Amid AstraZeneca Acquisition and Radiopharmaceutical Prospects
Analysts Offer Insights on Healthcare Companies: AstraZeneca (AZN), Intuitive Surgical (ISRG) and IN8bio (INAB)
Research Alert: CFRA Keeps Strong Buy Opinion On Adss Of Astrazeneca Plc
AstraZeneca's Growth Potential Bolstered by Strong Pipeline and Strategic Acquisitions: A Buy Rating Justified
Analysts Have Conflicting Sentiments on These Healthcare Companies: Healius Limited (Frankfurt: DE:PGZ), Cipher Pharmaceuticals (OtherCPHRF) and AstraZeneca (GB:AZN)
AstraZeneca: A Buy Rating With Promising Growth and Strategic R&D Outlook Despite Near-Term Challenges
Analysts Offer Insights on Healthcare Companies: Premier (PINC) and AstraZeneca (GB:AZN)
AstraZeneca Analyst Ratings
Analysts Conflicted on These Healthcare Names: GN Store Nord (GB:0K9P), AstraZeneca (GB:AZN) and Ipsen (GB:0MH6)
AstraZeneca: Solid Revenue Performance and Strong Growth Outlook Justify Buy Rating
AstraZeneca Analyst Ratings
Research Alert: CFRA Keeps Strong Buy Opinion On Adss Of Astrazeneca Plc
No Data